These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6437348

  • 1. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
    Rudge SR, Perrett D, Swannell AJ.
    Ann Rheum Dis; 1984 Oct; 43(5):698-702. PubMed ID: 6437348
    [Abstract] [Full Text] [Related]

  • 2. Free thiomalate in plasma and urine of patients receiving sodium aurothiomalate.
    Rudge SR, Perrett D, Swannell AJ.
    Ann Rheum Dis; 1984 Feb; 43(1):66-9. PubMed ID: 6696520
    [Abstract] [Full Text] [Related]

  • 3. Circulating thiomalate after administration of disodium aurothiomalate: impurity or active metabolite?
    Rudge SR, Perrett D, Swannell AJ, Drury PL.
    J Rheumatol; 1984 Apr; 11(2):150-2. PubMed ID: 6427462
    [Abstract] [Full Text] [Related]

  • 4. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E, Jellum E, Aaseth J.
    Rheumatol Rehabil; 1978 Apr; Suppl():105-8. PubMed ID: 103179
    [Abstract] [Full Text] [Related]

  • 5. Gold and thiol compounds in the treatment of rheumatoid arthritis: excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate).
    Jellum E, Munthe E, Guldal G, Aaseth J.
    Scand J Rheumatol Suppl; 1979 Apr; (28):28-36. PubMed ID: 109914
    [Abstract] [Full Text] [Related]

  • 6. Fate of the thiomalate part after intramuscular administration of aurothiomalate in rheumatoid arthritis.
    Jellum E, Munthe E.
    Ann Rheum Dis; 1982 Aug; 41(4):431-2. PubMed ID: 6810769
    [Abstract] [Full Text] [Related]

  • 7. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M, Nissilä M, Ruutsalo HM.
    Scand J Rheumatol; 1978 Aug; 7(4):212-4. PubMed ID: 104378
    [Abstract] [Full Text] [Related]

  • 8. Gold levels produced by treatment with auranofin and sodium aurothiomalate.
    Lewis D, Capell HA, McNeil CJ, Iqbal MS, Brown DH, Smith WE.
    Ann Rheum Dis; 1983 Oct; 42(5):566-70. PubMed ID: 6414387
    [Abstract] [Full Text] [Related]

  • 9. Gold concentrations in blood fractions of patients with rheumatoid arthritis treated with Myocrisin.
    Egila J, Littlejohn D, Smith WE, Sturrock RD.
    J Pharm Biomed Anal; 1992 Sep; 10(9):639-44. PubMed ID: 1286129
    [Abstract] [Full Text] [Related]

  • 10. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 11. Serum gold determinations in patients with rheumatoid arthritis receiving sodium aurothiomalate.
    Jessop JD, Johns RG.
    Ann Rheum Dis; 1973 May 15; 32(3):228-32. PubMed ID: 4268483
    [No Abstract] [Full Text] [Related]

  • 12. Fate of the gold and the thiomalate part after intramuscular administration of aurothiomalate to mice.
    Jellum E, Munthe E, Guldal G, Aaseth J.
    Ann Rheum Dis; 1980 Apr 15; 39(2):155-8. PubMed ID: 6770766
    [Abstract] [Full Text] [Related]

  • 13. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG, Morgan SH, Parke AL, Childs L, Goldman M, Hughes GR.
    Int J Clin Pharmacol Res; 1984 Apr 15; 4(6):395-401. PubMed ID: 6442711
    [Abstract] [Full Text] [Related]

  • 14. Comparison of two maintenance schedules of chrysotherapy in rheumatoid arthritis: preliminary report.
    Griffin AJ, Gibson T, Taylor A.
    Rheumatol Rehabil; 1978 Apr 15; Suppl():99-104. PubMed ID: 103181
    [Abstract] [Full Text] [Related]

  • 15. Gold therapy in rheumatoid arthritis.
    Majoos FL, Klemp P, Meyers OL, Briggs B.
    S Afr Med J; 1981 Jun 27; 59(27):971-4. PubMed ID: 6787722
    [Abstract] [Full Text] [Related]

  • 16. Measurement of 'free' gold in patients receiving disodium aurothiomalate and the association of high free to total gold levels with toxicity.
    Heath MJ.
    Ann Rheum Dis; 1988 Jan 27; 47(1):18-21. PubMed ID: 3125798
    [Abstract] [Full Text] [Related]

  • 17. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH, Griffin J, Panayi GS, Batchelor JR, Welsh KI, Gibson TJ.
    N Engl J Med; 1980 Aug 07; 303(6):300-2. PubMed ID: 6770269
    [Abstract] [Full Text] [Related]

  • 18. Patterns of gold levels in urine, serum, and saliva in patients with rheumatoid arthritis undergoing chrysotherapy.
    Heath MJ, Gillett GT, Swannell AJ, Williams CR, Palmer T.
    Ann Rheum Dis; 1987 Nov 07; 46(11):827-9. PubMed ID: 3122674
    [Abstract] [Full Text] [Related]

  • 19. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T, Hunter JA, Capell HA.
    Ann Rheum Dis; 1984 Feb 07; 43(1):18-23. PubMed ID: 6421253
    [Abstract] [Full Text] [Related]

  • 20. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P, Menard H, Thompson J, Harth M, Beaudet F.
    J Rheumatol; 1985 Feb 07; 12(1):60-7. PubMed ID: 3920393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.